BD® AbSeq Assay Enables Deeper Understanding of Role Individual Cells Play in the Immune System FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial release of the BD® AbSeq assay to analyze protein expression at the single-cell level using high-throughput sequencing. The assay brings together high-quality antibodies from […]

Wakefield, MA – Protein Dynamic Solutions LLC (PDS), developer of breakthrough technologies for biopharmaceutical characterization of therapeutic proteins, announces the appointment of Dr. Selena Larkin to its leadership team. PDS’ flagship product is a high-throughput drug developability and comparability assessment tool, ProteinMentorTM, which uses a unique combination of laser-microscopy and molecular spectrometry to determine aggregate size […]

MINNEAPOLIS — Bio-Techne again disrupts protein analysis technology with the introduction of the newest member of their ProteinSimple-branded Simple Western family, Jess. This evolutionary technology simplifies protein expression analysis, while speeding up time to result. Jess automates both the protein separation and immunodetection elements characteristic of traditional protein analysis techniques, eliminating many of the tedious, error-prone steps. […]

MONTREAL’S MÉDIMABS TO DISTRIBUTE REAGENT ANTIBODIES TO INTERNATIONAL MARKET Toronto, ON, Canada – The Centre for the Commercialization of Antibodies and Biologics (CCAB) and MédiMabs Antibodies have signed an agreement for the distribution of CCAB’s reagent antibodies. The agreement marks the launch of a new business segment for CCAB and allows MédiMabs to expand its portfolio to include human synthetic […]

Combining the world-leading proteomic and artificial intelligence/machine learning technologies to produce novel, actionable health insights across many diseases, conditions and markets SomaLogic and GNS Healthcare announced today that SomaLogic has obtained a license to apply GNS Healthcare’s proprietary REFS™ (Reverse Engineering & Forward Simulation) causal machine learning technology to SomaLogic’s proprietary SOMAscan®-derived protein data sets. […]

SAN FRANCISCO — Enable Biosciences Inc was awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II grant for $750,000 to commercialize ultrasensitive and multiplexable immunoassays for both research and clinical diagnostic use. Over 70% of clinical decisions are informed by lab tests, many of which rely on detecting antibody biomarkers. “For hundreds of infectious and autoimmune diseases and cancer, early […]

Consortium chooses Genedata Selector as bioinformatics solution for production of industrial polyketides. Munich, Germany Genedata, a leading provider of advanced software solutions for R&D, today announced that the MyBio consortium has chosen Genedata Selector® as its genome management and characterization platform to support its highly innovative R&D work in antibiotics. MyBio is an interdisciplinary consortia […]

PALO ALTO, Calif.–Science Exchange, the leading marketplace for outsourced R&D™, announces a collaboration with LI-COR Biosciences to offer a suite of molecular imaging services based on LI-COR’s pioneer work in near-infrared fluorescence as a detection method. Based in Lincoln, Nebraska, LI-COR Biosciences is a world leader in innovative imaging systems for proteomics and pre-clinical research. With […]

Knockout Validation of Antibodies Confirms Specificity and Ensures Reproducible Results MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH), a family of brands with a unique and leading portfolio of antibody-based reagents for life science and clinical research, has been validating an extensive and growing number of antibodies using recent advances in gene editing technology. The specificity and power […]

Gyros Protein Technologies to develop immunoassay kits for biotherapeutic impurity analysis using Cygnus Technologies’ proprietary reagents Uppsala, Sweden and Southport, N.C. ­– Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, and Cygnus Technologies, the leading assay and services provider for the detection and characterization of impurities […]